Advertise
NEWSLETTER
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Kizoo
Reservoir Neuroscience set to restore health to the aging brain

Reservoir Neuroscience set to restore health to the aging brain

Mogling Bio secures additional funding to advance rejuvenation tech

Cellvie closes $5.5m to accelerate development of Therapeutic Mitochondria Transplantation

MoglingBio closes seed investment round with Kizoo Technology Capital.

Kizoo invests in rejuvenation startup Mogling Bio

Underdog Pharmaceuticals' success means its name needs to change. Enter Cyclarity, which takes up residence in state-of-the-art labs at the Buck Institute for Research on Aging.

Underdog becomes Cyclarity – and moves to the Buck Institute

Funding used to accelerate vascular treatment development ahead of next year's clinical trials in humans.

Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round

Led by Kizoo Technology Capital, the Seed round will be used to advance Revel Pharmaceuticals’ enzyme therapy pipeline towards the clinic.

Revel announces $8.4m for repairing-based approaches to reversing aging

Longevity.Technology Founder and CEO will share his outlook on the longevity investment landscape at key summit in Berlin.

Phil Newman to speak at Rejuvenation Startup Summit 2022

Naren Vyavahare

Elastrin limbers up for success with Kizoo funding boost

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed